Cargando…

Response to ‘Comments on 'The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study''

Detalles Bibliográficos
Autor principal:	Narod, Steven A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997548/ https://www.ncbi.nlm.nih.gov/pubmed/27459693 http://dx.doi.org/10.1038/bjc.2016.225

Ejemplares similares

Comment on ‘The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study'
por: Friedenson, Bernard
Publicado: (2016)

Comment on ‘The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study'
por: Paradiso, A V, et al.
Publicado: (2016)

The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study
por: Iqbal, Javaid, et al.
Publicado: (2016)

Looking for BRCA1 and BRCA2 mutations in Asian women with breast cancer
por: Narod, Steven A.
Publicado: (2023)

Breast cancer prevention in women with a BRCA1 or BRCA2 mutation
por: Metcalfe, Kelly A, et al.
Publicado: (2007)

Reply: Reduced DNA repair in BRCA1 mutation carriers undetectable before onset of breast cancer?
por: Narod, S A
Publicado: (2007)

Effect of the novel Moroccan BRCA1 and BRCA2 frameshift mutations
por: Tazzite, Amal, et al.
Publicado: (2013)

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
por: Iqbal, J, et al.
Publicado: (2012)

Comparison of Targeted Next-Generation and Sanger Sequencing for the BRCA1 and BRCA2 Mutation Screening
por: Park, Joonhong, et al.
Publicado: (2016)

International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation
por: Metcalfe, Kelly, et al.
Publicado: (2019)

BRCA2 Reversion Mutation Identified by Liquid Biopsy After Durable Response to FOLFIRINOX in BRCA2-Associated Pancreatic Cancer
por: Kondo, Tomohiro, et al.
Publicado: (2020)

Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

Short report: Follow‐up of Bahamian women with a BRCA1 or BRCA2 mutation
por: Narod, Steven A., et al.
Publicado: (2017)

Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation
por: Mansfield, Carol A., et al.
Publicado: (2020)

Comment on: Endometrial cancer occurrence five years after breast cancer in BRCA2 mutation patient
por: Choi, Min Chul, et al.
Publicado: (2015)

Choices for cancer prevention for women with a BRCA1 mutation? a personal view
por: Narod, Steven A.
Publicado: (2023)

Plasma RANKL levels are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Zaman, Tasnim, et al.
Publicado: (2019)

Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Odén, Lovisa, et al.
Publicado: (2016)

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece
por: Koumpis, Chrissovaladis, et al.
Publicado: (2011)

Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort
por: Liu, Yun, et al.
Publicado: (2021)

Prospective study of high-risk, BRCA1/2-mutation negative women: the ‘negative study’
por: Kotsopoulos, Joanne, et al.
Publicado: (2014)

Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation
por: Metcalfe, Kelly A, et al.
Publicado: (2007)

Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific
por: Chehade, Rania, et al.
Publicado: (2016)

Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients
por: Kwong, Ava, et al.
Publicado: (2012)

Analysis of PTEN in two BRCA1 and BRCA2 wild-type familial breast cancer patients
por: Akouchekian, Mansoureh, et al.
Publicado: (2015)

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Metcalfe, K, et al.
Publicado: (2011)

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Kotsopoulos, Joanne, et al.
Publicado: (2012)

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study
por: Phelan, C M, et al.
Publicado: (2014)

Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Kotsopoulos, Joanne, et al.
Publicado: (2005)

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women
por: Rebbeck, Timothy R., et al.
Publicado: (2016)

BRCA1 c.4987-3C>G is a pathogenic mutation
por: Brandão, Rita D., et al.
Publicado: (2011)

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia
por: Hernández, Julián Esteban Londoño, et al.
Publicado: (2014)

Physical Activity During Adolescence and Early-adulthood and Ovarian Cancer Among Women with a BRCA1 or BRCA2 Mutation
por: Guyonnet, Emma, et al.
Publicado: (2023)

BRCA1 founder mutations compared to ovarian cancer in Belarus
por: Savanevich, Alena, et al.
Publicado: (2014)

Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study
por: de Jonge, Marthe M, et al.
Publicado: (2021)

Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
por: Metcalfe, Kelly A, et al.
Publicado: (2005)

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
por: Metcalfe, Kelly, et al.
Publicado: (2014)

Evaluation of BRCA1 and BRCA2 as Indicators of Response to Immune Checkpoint Inhibitors
por: Zhou, Zhijun, et al.
Publicado: (2021)

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
por: Mavaddat, Nasim, et al.
Publicado: (2020)

BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ
por: Liu, Yan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_caokura043grs27ik6d0p6fbeg